Skip to main content
. 2021 Jan 13;74(7):608–615. doi: 10.1016/j.rec.2020.12.009

Figure 3.

Figure 3

Kaplan-Meier survival landmark analysis according to the CHA2DS2-VASc score. Group 1: CHA2DS2-VASc = 0 in men and ≤ 1 in women; Group 2: CHA2DS2-VASc = 1 in men or 2 in women; and Group 3: CHA2DS2-VASc > 1 in men or > 2 in women. A: entire cohort. B: patients without AF. C: patients with AF.